Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New Developments in Angiogenic Therapy Emerging from Oxford

26.08.2002


Angiogenesis, the growth of new blood vessels, is important in the healthy body for healing wounds and, in females, for the monthly reproductive cycle and during pregnancy. It is controlled in the body through the use of the body’s own angiogenesis inhibitors and stimulators. In certain diseases the body is unable to control blood vessel growth. In diseases such as cancer, diabetic blindness and psoriasis, excessive angiogenesis is occurring; and in diseases such as coronary artery disease and stroke insufficient angiogenesis is the problem.



A novel anti-angiogenic agent

Researchers in the Cancer Research UK Molecular Oncology Laboratory at Oxford University have now identified a new inhibitor of endothelial cell proliferation with possible applications in the treatment of those disorders listed above which are characterised by excessive angiogenesis.


For example, solid cancer tumours are often characterised as being angiogenic, i.e. having an increased blood supply. One promising new treatment for solid tumours proposes to cut off the tumour’s blood supply with subsequent tumour shrinkage. Endothelial cells that line normal blood vessels are usually quiescent while those within tumour blood vessels are proliferating. Anti-angiogenic agents that can selectively inhibit proliferating endothelial cells or cytotoxic agents that can be delivered to the tumour vasculature have huge potential for the treatment of solid tumours.

Oxford, Imperial College and Cancer Research UK scientists, led by Professor Adrian Harris, have now identified a new agent for solving this problem. An anti-angiogenic peptide has been isolated and characterised. This peptide is a new member of the family of anti-angiogenic molecules that includes angiostatin which have for some years been of great interest to the pharmaceutical community. It has been shown in experiments to be an effective inhibitor of endothelial cell proliferation.

A new lead in the fight against Coronary Artery Disease

Alternatively, it has been found that the antibody to the peptide is effective in promoting the proliferation of endothelial cells and is thus a potential angiogenic agent for the treatment of disorders such as coronary artery disease. Angiogenic therapy can alleviate coronary artery disease by stimulating new vessel growth and returning blood flow to the heart, through the delivery of angiogenic proteins or their genes to this organ. Endothelial cells that line blood vessels are the initial targets for promoting new vessel growth. Therefore new biological agents that can stimulate endothelial cell growth, such as this antibody, are important candidates for angiogenic therapy.

Isis Innovation, Oxford University’s technology transfer company, holds the patent application for this project and is actively seeking partners for the licensing and commercial development of these technologies.

Jennifer Johnson | alfa
Further information:
http://www.isis-innovation.com/licensing/779.html

More articles from Health and Medicine:

nachricht New leukemia treatment offers hope
23.09.2016 | King Abdullah University of Science and Technology

nachricht Alzheimer’s: Cellular Mechanism Provides Explanation Model for Declining Memory Performance
21.09.2016 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: OLED microdisplays in data glasses for improved human-machine interaction

The Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP has been developing various applications for OLED microdisplays based on organic semiconductors. By integrating the capabilities of an image sensor directly into the microdisplay, eye movements can be recorded by the smart glasses and utilized for guidance and control functions, as one example. The new design will be debuted at Augmented World Expo Europe (AWE) in Berlin at Booth B25, October 18th – 19th.

“Augmented-reality” and “wearables” have become terms we encounter almost daily. Both can make daily life a little simpler and provide valuable assistance for...

Im Focus: Artificial Intelligence Helps in the Discovery of New Materials

With the help of artificial intelligence, chemists from the University of Basel in Switzerland have computed the characteristics of about two million crystals made up of four chemical elements. The researchers were able to identify 90 previously unknown thermodynamically stable crystals that can be regarded as new materials. They report on their findings in the scientific journal Physical Review Letters.

Elpasolite is a glassy, transparent, shiny and soft mineral with a cubic crystal structure. First discovered in El Paso County (Colorado, USA), it can also be...

Im Focus: Complex hardmetal tools out of the 3D printer

For the first time, Fraunhofer IKTS shows additively manufactured hardmetal tools at WorldPM 2016 in Hamburg. Mechanical, chemical as well as a high heat resistance and extreme hardness are required from tools that are used in mechanical and automotive engineering or in plastics and building materials industry. Researchers at the Fraunhofer Institute for Ceramic Technologies and Systems IKTS in Dresden managed the production of complex hardmetal tools via 3D printing in a quality that are in no way inferior to conventionally produced high-performance tools.

Fraunhofer IKTS counts decades of proven expertise in the development of hardmetals. To date, reliable cutting, drilling, pressing and stamping tools made of...

Im Focus: Launch of New Industry Working Group for Process Control in Laser Material Processing

At AKL’16, the International Laser Technology Congress held in May this year, interest in the topic of process control was greater than expected. Appropriately, the event was also used to launch the Industry Working Group for Process Control in Laser Material Processing. The group provides a forum for representatives from industry and research to initiate pre-competitive projects and discuss issues such as standards, potential cost savings and feasibility.

In the age of industry 4.0, laser technology is firmly established within manufacturing. A wide variety of laser techniques – from USP ablation and additive...

Im Focus: New laser joining technologies at ‘K 2016’ trade fair

Every three years, the plastics industry gathers at K, the international trade fair for plastics and rubber in Düsseldorf. The Fraunhofer Institute for Laser Technology ILT will also be attending again and presenting many innovative technologies, such as for joining plastics and metals using ultrashort pulse lasers. From October 19 to 26, you can find the Fraunhofer ILT at the joint Fraunhofer booth SC01 in Hall 7.

K is the world’s largest trade fair for the plastics and rubber industry. As in previous years, the organizers are expecting 3,000 exhibitors and more than...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Experts from industry and academia discuss the future mobile telecommunications standard 5G

23.09.2016 | Event News

ICPE in Graz for the seventh time

20.09.2016 | Event News

Using mathematical models to understand our brain

16.09.2016 | Event News

 
Latest News

Chains of nanogold – forged with atomic precision

23.09.2016 | Life Sciences

New leukemia treatment offers hope

23.09.2016 | Health and Medicine

Self-assembled nanostructures hit their target

23.09.2016 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>